शेयर मूल्य

तारीख	Kalbe Farma Tbk PT शेयर मूल्य
20/9/2024	1,720.00 IDR
19/9/2024	1,730.00 IDR
18/9/2024	1,750.00 IDR
17/9/2024	1,705.00 IDR
13/9/2024	1,705.00 IDR
12/9/2024	1,740.00 IDR
11/9/2024	1,720.00 IDR
10/9/2024	1,740.00 IDR
9/9/2024	1,740.00 IDR
6/9/2024	1,710.00 IDR
5/9/2024	1,690.00 IDR
4/9/2024	1,730.00 IDR
3/9/2024	1,680.00 IDR
2/9/2024	1,680.00 IDR
30/8/2024	1,650.00 IDR
29/8/2024	1,700.00 IDR
28/8/2024	1,725.00 IDR
27/8/2024	1,740.00 IDR
26/8/2024	1,730.00 IDR
23/8/2024	1,720.00 IDR

तारीख	Kalbe Farma Tbk PT राजस्व	Kalbe Farma Tbk PT EBIT	Kalbe Farma Tbk PT लाभ
2026e	38.52 जैव. IDR	4.95 जैव. IDR	3.85 जैव. IDR
2025e	35.7 जैव. IDR	4.48 जैव. IDR	3.5 जैव. IDR
2024e	30.17 जैव. IDR	4.08 जैव. IDR	3.21 जैव. IDR
2023	30.45 जैव. IDR	3.63 जैव. IDR	2.77 जैव. IDR
2022	28.93 जैव. IDR	4.22 जैव. IDR	3.38 जैव. IDR
2021	26.26 जैव. IDR	4 जैव. IDR	3.18 जैव. IDR
2020	23.11 जैव. IDR	3.55 जैव. IDR	2.73 जैव. IDR
2019	22.63 जैव. IDR	3.3 जैव. IDR	2.51 जैव. IDR
2018	21.07 जैव. IDR	3.17 जैव. IDR	2.46 जैव. IDR
2017	20.18 जैव. IDR	3.15 जैव. IDR	2.4 जैव. IDR
2016	19.37 जैव. IDR	3.01 जैव. IDR	2.3 जैव. IDR
2015	17.89 जैव. IDR	2.72 जैव. IDR	2 जैव. IDR
2014	17.37 जैव. IDR	2.84 जैव. IDR	2.07 जैव. IDR
2013	16 जैव. IDR	2.53 जैव. IDR	1.92 जैव. IDR
2012	13.64 जैव. IDR	2.21 जैव. IDR	1.73 जैव. IDR
2011	10.91 जैव. IDR	-4.21 जैव. IDR	1.49 जैव. IDR
2010	10.23 जैव. IDR	1.79 जैव. IDR	1.29 जैव. IDR
2009	9.09 जैव. IDR	1.57 जैव. IDR	929 अरब IDR
2008	7.88 जैव. IDR	1.14 जैव. IDR	706.82 अरब IDR
2007	7 जैव. IDR	1.13 जैव. IDR	705.69 अरब IDR
2006	6.07 जैव. IDR	1.07 जैव. IDR	676.58 अरब IDR
2005	5.87 जैव. IDR	1.11 जैव. IDR	653.33 अरब IDR
2004	3.41 जैव. IDR	733.59 अरब IDR	372.34 अरब IDR

	राजस्व	EBIT	लाभ
2004	3.41 जैव. IDR	733.59 अरब IDR	372.34 अरब IDR
2005	5.87 जैव. IDR	1.11 जैव. IDR	653.33 अरब IDR
2006	6.07 जैव. IDR	1.07 जैव. IDR	676.58 अरब IDR
2007	7 जैव. IDR	1.13 जैव. IDR	705.69 अरब IDR
2008	7.88 जैव. IDR	1.14 जैव. IDR	706.82 अरब IDR
2009	9.09 जैव. IDR	1.57 जैव. IDR	929 अरब IDR
2010	10.23 जैव. IDR	1.79 जैव. IDR	1.29 जैव. IDR
2011	10.91 जैव. IDR	-4.21 जैव. IDR	1.49 जैव. IDR
2012	13.64 जैव. IDR	2.21 जैव. IDR	1.73 जैव. IDR
2013	16 जैव. IDR	2.53 जैव. IDR	1.92 जैव. IDR
2014	17.37 जैव. IDR	2.84 जैव. IDR	2.07 जैव. IDR
2015	17.89 जैव. IDR	2.72 जैव. IDR	2 जैव. IDR
2016	19.37 जैव. IDR	3.01 जैव. IDR	2.3 जैव. IDR
2017	20.18 जैव. IDR	3.15 जैव. IDR	2.4 जैव. IDR
2018	21.07 जैव. IDR	3.17 जैव. IDR	2.46 जैव. IDR
2019	22.63 जैव. IDR	3.3 जैव. IDR	2.51 जैव. IDR
2020	23.11 जैव. IDR	3.55 जैव. IDR	2.73 जैव. IDR
2021	26.26 जैव. IDR	4 जैव. IDR	3.18 जैव. IDR
2022	28.93 जैव. IDR	4.22 जैव. IDR	3.38 जैव. IDR
2023	30.45 जैव. IDR	3.63 जैव. IDR	2.77 जैव. IDR
2024e	30.17 जैव. IDR	4.08 जैव. IDR	3.21 जैव. IDR
2025e	35.7 जैव. IDR	4.48 जैव. IDR	3.5 जैव. IDR
2026e	38.52 जैव. IDR	4.95 जैव. IDR	3.85 जैव. IDR

Kalbe Farma Tbk PT सकल मार्जिन	Kalbe Farma Tbk PT लाभ मार्जिन	Kalbe Farma Tbk PT EBIT मार्जिन	Kalbe Farma Tbk PT लाभ मार्जिन
2026e	37.6 %	12.86 %	10 %
2025e	37.6 %	12.54 %	9.81 %
2024e	37.6 %	13.53 %	10.62 %
2023	37.6 %	11.91 %	9.09 %
2022	39.81 %	14.59 %	11.69 %
2021	42.28 %	15.21 %	12.12 %
2020	43.48 %	15.38 %	11.83 %
2019	44.3 %	14.6 %	11.08 %
2018	46.2 %	15.06 %	11.66 %
2017	48.24 %	15.59 %	11.91 %
2016	48.35 %	15.54 %	11.87 %
2015	48.03 %	15.22 %	11.2 %
2014	48.8 %	16.37 %	11.9 %
2013	47.99 %	15.8 %	12 %
2012	47.91 %	16.22 %	12.72 %
2011	50.87 %	-38.59 %	13.68 %
2010	50.52 %	17.51 %	12.58 %
2009	49.65 %	17.23 %	10.22 %
2008	48.29 %	14.51 %	8.97 %
2007	50.7 %	16.12 %	10.07 %
2006	51.04 %	17.64 %	11.14 %
2005	51.26 %	18.84 %	11.13 %
2004	57.08 %	21.49 %	10.91 %

	सकल मार्जिन	EBIT मार्जिन	लाभ मार्जिन
2004	57.08 %	21.49 %	10.91 %
2005	51.26 %	18.84 %	11.13 %
2006	51.04 %	17.64 %	11.14 %
2007	50.7 %	16.12 %	10.07 %
2008	48.29 %	14.51 %	8.97 %
2009	49.65 %	17.23 %	10.22 %
2010	50.52 %	17.51 %	12.58 %
2011	50.87 %	-38.59 %	13.68 %
2012	47.91 %	16.22 %	12.72 %
2013	47.99 %	15.8 %	12 %
2014	48.8 %	16.37 %	11.9 %
2015	48.03 %	15.22 %	11.2 %
2016	48.35 %	15.54 %	11.87 %
2017	48.24 %	15.59 %	11.91 %
2018	46.2 %	15.06 %	11.66 %
2019	44.3 %	14.6 %	11.08 %
2020	43.48 %	15.38 %	11.83 %
2021	42.28 %	15.21 %	12.12 %
2022	39.81 %	14.59 %	11.69 %
2023	37.6 %	11.91 %	9.09 %
2024e	37.6 %	13.53 %	10.62 %
2025e	37.6 %	12.54 %	9.81 %
2026e	37.6 %	12.86 %	10 %

तारीख	Kalbe Farma Tbk PT प्रति शेयर बिक्री	Kalbe Farma Tbk PT EBIT प्रति शेयर	Kalbe Farma Tbk PT प्रति शेयर लाभ
2026e	832.99 IDR	0 IDR	83.26 IDR
2025e	772.05 IDR	0 IDR	75.71 IDR
2024e	652.45 IDR	0 IDR	69.31 IDR
2023	658.28 IDR	78.37 IDR	59.81 IDR
2022	622.01 IDR	90.78 IDR	72.71 IDR
2021	560.26 IDR	85.24 IDR	67.92 IDR
2020	493.09 IDR	75.82 IDR	58.31 IDR
2019	482.85 IDR	70.5 IDR	53.48 IDR
2018	449.58 IDR	67.7 IDR	52.42 IDR
2017	430.55 IDR	67.14 IDR	51.28 IDR
2016	413.32 IDR	64.23 IDR	49.06 IDR
2015	381.6 IDR	58.06 IDR	42.76 IDR
2014	370.53 IDR	60.67 IDR	44.08 IDR
2013	341.38 IDR	53.95 IDR	40.95 IDR
2012	290.91 IDR	47.2 IDR	36.99 IDR
2011	232.79 IDR	-89.83 IDR	31.85 IDR
2010	218.19 IDR	38.21 IDR	27.44 IDR
2009	189.77 IDR	32.7 IDR	19.4 IDR
2008	161.5 IDR	23.43 IDR	14.49 IDR
2007	138.85 IDR	22.39 IDR	13.99 IDR
2006	119.57 IDR	21.1 IDR	13.32 IDR
2005	115.62 IDR	21.79 IDR	12.87 IDR
2004	84.05 IDR	18.07 IDR	9.17 IDR

	प्रति शेयर बिक्री	EBIT प्रति शेयर	प्रति शेयर लाभ
2004	84.05 IDR	18.07 IDR	9.17 IDR
2005	115.62 IDR	21.79 IDR	12.87 IDR
2006	119.57 IDR	21.1 IDR	13.32 IDR
2007	138.85 IDR	22.39 IDR	13.99 IDR
2008	161.5 IDR	23.43 IDR	14.49 IDR
2009	189.77 IDR	32.7 IDR	19.4 IDR
2010	218.19 IDR	38.21 IDR	27.44 IDR
2011	232.79 IDR	-89.83 IDR	31.85 IDR
2012	290.91 IDR	47.2 IDR	36.99 IDR
2013	341.38 IDR	53.95 IDR	40.95 IDR
2014	370.53 IDR	60.67 IDR	44.08 IDR
2015	381.6 IDR	58.06 IDR	42.76 IDR
2016	413.32 IDR	64.23 IDR	49.06 IDR
2017	430.55 IDR	67.14 IDR	51.28 IDR
2018	449.58 IDR	67.7 IDR	52.42 IDR
2019	482.85 IDR	70.5 IDR	53.48 IDR
2020	493.09 IDR	75.82 IDR	58.31 IDR
2021	560.26 IDR	85.24 IDR	67.92 IDR
2022	622.01 IDR	90.78 IDR	72.71 IDR
2023	658.28 IDR	78.37 IDR	59.81 IDR
2024e	652.45 IDR	0 IDR	69.31 IDR
2025e	772.05 IDR	0 IDR	75.71 IDR
2026e	832.99 IDR	0 IDR	83.26 IDR

	अंश की संख्या
2004	40.61 अरब Aktien
2005	50.78 अरब Aktien
2006	50.78 अरब Aktien
2007	50.45 अरब Aktien
2008	48.78 अरब Aktien
2009	47.89 अरब Aktien
2010	46.87 अरब Aktien
2011	46.88 अरब Aktien
2012	46.88 अरब Aktien
2013	46.88 अरब Aktien
2014	46.88 अरब Aktien
2015	46.88 अरब Aktien
2016	46.88 अरब Aktien
2017	46.88 अरब Aktien
2018	46.88 अरब Aktien
2019	46.88 अरब Aktien
2020	46.87 अरब Aktien
2021	46.87 अरब Aktien
2022	46.52 अरब Aktien
2023	46.26 अरब Aktien
2024e	46.26 अरब Aktien
2025e	46.26 अरब Aktien
2026e	46.26 अरब Aktien

तारीख	Kalbe Farma Tbk PT लाभांश
2026e	41.56 IDR
2025e	41.54 IDR
2024e	41.58 IDR
2023	38 IDR
2021	28 IDR
2020	26 IDR
2019	26 IDR
2018	25 IDR
2017	22 IDR
2016	19 IDR
2015	19 IDR
2014	17 IDR
2013	19 IDR
2012	19 IDR
2011	14 IDR
2010	5 IDR
2009	2.5 IDR
2008	2 IDR
2007	2 IDR
2005	0.6 IDR
2004	0.2 IDR

	लाभांश	डिविडेंड (अनुमान)
2004	0.2 IDR	0 IDR
2005	0.6 IDR	0 IDR
2006	0 IDR	0 IDR
2007	2 IDR	0 IDR
2008	2 IDR	0 IDR
2009	2.5 IDR	0 IDR
2010	5 IDR	0 IDR
2011	14 IDR	0 IDR
2012	19 IDR	0 IDR
2013	19 IDR	0 IDR
2014	17 IDR	0 IDR
2015	19 IDR	0 IDR
2016	19 IDR	0 IDR
2017	22 IDR	0 IDR
2018	25 IDR	0 IDR
2019	26 IDR	0 IDR
2020	26 IDR	0 IDR
2021	28 IDR	0 IDR
2022	0 IDR	0 IDR
2023	38 IDR	0 IDR
2024e	0 IDR	41.58 IDR
2025e	0 IDR	41.54 IDR
2026e	0 IDR	41.56 IDR

तारीख	Kalbe Farma Tbk PT वितरण अनुपात
2026e	43.53 %
2025e	43.85 %
2024e	43.19 %
2023	43.54 %
2022	44.81 %
2021	41.22 %
2020	44.59 %
2019	48.62 %
2018	47.69 %
2017	42.9 %
2016	38.73 %
2015	44.44 %
2014	38.57 %
2013	46.4 %
2012	51.37 %
2011	43.96 %
2010	18.22 %
2009	12.89 %
2008	13.8 %
2007	14.3 %
2006	44.81 %
2005	4.66 %
2004	2.18 %

	वितरण अनुपात
2004	2.18 %
2005	4.66 %
2006	44.81 %
2007	14.3 %
2008	13.8 %
2009	12.89 %
2010	18.22 %
2011	43.96 %
2012	51.37 %
2013	46.4 %
2014	38.57 %
2015	44.44 %
2016	38.73 %
2017	42.9 %
2018	47.69 %
2019	48.62 %
2020	44.59 %
2021	41.22 %
2022	44.81 %
2023	43.54 %
2024e	43.19 %
2025e	43.85 %
2026e	43.53 %

तिथि	EPS-अनुमान	वास्तविक EPS	रिपोर्टिंग तिमाही
30/6/2024	17.29 IDR	18.23 IDR (5.41 %)	2024 Q2
31/3/2024	18.52 IDR	20.7 IDR (11.75 %)	2024 Q1
31/12/2023	16.13 IDR	15.42 IDR (-4.38 %)	2023 Q4
30/9/2023	17.92 IDR	11.52 IDR (-35.71 %)	2023 Q3
30/6/2023	20.69 IDR	14.47 IDR (-30.05 %)	2023 Q2
31/3/2023	20.01 IDR	18.4 IDR (-8.03 %)	2023 Q1
31/12/2022	20.89 IDR	19.27 IDR (-7.77 %)	2022 Q4
30/9/2022	19.05 IDR	18.33 IDR (-3.81 %)	2022 Q3
30/6/2022	19.17 IDR	17.26 IDR (-9.93 %)	2022 Q2
31/3/2022	18.67 IDR	17.85 IDR (-4.37 %)	2022 Q1
31/12/2021	17.32 IDR	19.11 IDR (10.38 %)	2021 Q4
30/9/2021	15.41 IDR	16.87 IDR (9.46 %)	2021 Q3
30/6/2021	16.16 IDR	16.65 IDR (3.06 %)	2021 Q2
31/3/2021	15.03 IDR	15.29 IDR (1.73 %)	2021 Q1
31/12/2020	14.81 IDR	15.06 IDR (1.66 %)	2020 Q4
30/9/2020	14.81 IDR	13.65 IDR (-7.8 %)	2020 Q3
30/6/2020	15.31 IDR	15.32 IDR (0.06 %)	2020 Q2
31/3/2020	13.48 IDR	14.28 IDR (5.9 %)	2020 Q1
31/12/2019	15.7 IDR	12.62 IDR (-19.63 %)	2019 Q4
30/9/2019	14.68 IDR	14.02 IDR (-4.52 %)	2019 Q3
30/6/2019	15 IDR	14.15 IDR (-5.65 %)	2019 Q2
31/3/2019	13.32 IDR	12.69 IDR (-4.74 %)	2019 Q1
31/12/2018	14.38 IDR	13.93 IDR (-3.11 %)	2018 Q4
30/9/2018	13.08 IDR	12.55 IDR (-4.02 %)	2018 Q3
30/6/2018	14.44 IDR	13.37 IDR (-7.39 %)	2018 Q2
31/3/2018	13.62 IDR	12.57 IDR (-7.74 %)	2018 Q1
31/12/2017	13.97 IDR	13.32 IDR (-4.67 %)	2017 Q4
30/9/2017	13.26 IDR	12.01 IDR (-9.45 %)	2017 Q3
30/6/2017	14.09 IDR	13.4 IDR (-4.93 %)	2017 Q2
31/3/2017	13.47 IDR	12.55 IDR (-6.82 %)	2017 Q1
31/12/2016	14.2 IDR	12.74 IDR (-10.29 %)	2016 Q4
30/9/2016	11 IDR	11.87 IDR (7.96 %)	2016 Q3
31/3/2016	12.44 IDR	12.02 IDR (-3.4 %)	2016 Q1
31/12/2015	10.29 IDR	10.76 IDR (4.53 %)	2015 Q4
30/9/2015	11.32 IDR	9.3 IDR (-17.84 %)	2015 Q3
30/6/2015	12.37 IDR	12 IDR (-3.03 %)	2015 Q2
30/6/2014	12.21 IDR	10 IDR (-18.08 %)	2014 Q2
31/3/2014	11.35 IDR	11 IDR (-3.06 %)	2014 Q1
31/12/2013	11.17 IDR	12 IDR (7.44 %)	2013 Q4
30/9/2013	9.88 IDR	9 IDR (-8.94 %)	2013 Q3
30/6/2013	9.62 IDR	10 IDR (4 %)	2013 Q2
31/12/2012	9.61 IDR	10.4 IDR (8.27 %)	2012 Q4
30/9/2012	9.34 IDR	47 IDR (403.48 %)	2012 Q3
30/6/2012	7.88 IDR	8.6 IDR (9.2 %)	2012 Q2
31/3/2012	7.42 IDR	8.6 IDR (15.91 %)	2012 Q1
31/12/2011	8.15 IDR	8.8 IDR (7.93 %)	2011 Q4
30/9/2011	7.42 IDR	8.4 IDR (13.24 %)	2011 Q3
30/6/2011	7.52 IDR	7.6 IDR (1.13 %)	2011 Q2
31/3/2011	6.53 IDR	6.8 IDR (4.14 %)	2011 Q1
31/12/2010	7.48 IDR	8.2 IDR (9.6 %)	2010 Q4
30/9/2010	7.04 IDR	7 IDR (-0.52 %)	2010 Q3
30/6/2010	7.23 IDR	6.8 IDR (-5.97 %)	2010 Q2
31/3/2010	5.99 IDR	5.4 IDR (-9.91 %)	2010 Q1
31/12/2009	5.8 IDR	6.6 IDR (13.78 %)	2009 Q4
30/9/2009	4.09 IDR	4.6 IDR (12.51 %)	2009 Q3
30/6/2009	4.71 IDR	3.8 IDR (-19.32 %)	2009 Q2
31/3/2009	3.6 IDR	4.4 IDR (22.19 %)	2009 Q1
31/12/2008	2.08 IDR	4.2 IDR (101.55 %)	2008 Q4
30/9/2008	2.56 IDR	3.4 IDR (32.68 %)	2008 Q3
30/6/2008	5.75 IDR	3.4 IDR (-40.91 %)	2008 Q2
31/12/2007	3.39 IDR	2 IDR (-41.02 %)	2007 Q4
30/9/2007	3.54 IDR	3.8 IDR (7.41 %)	2007 Q3
30/6/2007	4.93 IDR	3.8 IDR (-22.99 %)	2007 Q2
31/12/2006	4.05 IDR	2.76 IDR (-31.93 %)	2006 Q4
30/9/2006	4.34 IDR	2.8 IDR (-35.56 %)	2006 Q3
30/6/2006	3.98 IDR	3.84 IDR (-3.51 %)	2006 Q2
31/3/2006	3.94 IDR	4 IDR (1.52 %)	2006 Q1
31/12/2005	4.2 IDR	2.09 IDR (-50.19 %)	2005 Q4
30/9/2005	2.38 IDR	3.04 IDR (27.81 %)	2005 Q3
30/6/2005	3.34 IDR	3.74 IDR (12 %)	2005 Q2
31/3/2005	3.92 IDR	3.93 IDR (0.29 %)	2005 Q1
31/3/2004	3.06 IDR	3.1 IDR (1.31 %)	2004 Q1
30/6/2003	2.41 IDR	2.03 IDR (-15.88 %)	2003 Q2

%	नाम	शेयर	परिवर्तन	तारीख
9.63343 %	PT Diptanala Bahana	4,45,48,07,040	0	30/9/2023
9.60119 %	PT Lucasta Murni Cemerlang	4,43,98,95,440	0	30/9/2023
8.30747 %	PT Bina Arta Charisma	3,84,16,39,040	0	30/9/2023
2.04912 %	RBC Global Asset Management (UK) Limited	94,75,79,169	-3,32,30,100	29/2/2024
10.60304 %	PT Ladang Ira Panen	4,90,31,85,740	0	30/9/2023
10.43291 %	PT Gira Sole Prima	4,82,45,09,485	0	30/9/2023
10.20285 %	PT Santa Seha Sanadi	4,71,81,21,940	0	30/9/2023
1.81244 %	First Sentier Investors (Hong Kong) Limited	83,81,30,600	-17,99,600	31/12/2023
1.39315 %	Norges Bank Investment Management (NBIM)	64,42,36,998	10,61,66,961	31/12/2023
1.35347 %	BlackRock Institutional Trust Company, N.A.	62,58,88,368	55,56,600	31/3/2024
1.30253 %	The Vanguard Group, Inc.	60,23,32,113	0	31/3/2024
0.96561 %	Invesco Advisers, Inc.	44,65,29,900	0	29/2/2024
0.56953 %	BlackRock Advisors (UK) Limited	26,33,68,559	67,64,000	31/3/2024
0.48592 %	MFS Investment Management	22,47,05,600	0	29/2/2024
0.28112 %	Banque de Luxembourg Investments	13,00,00,000	0	31/12/2023
0.24024 %	First Sentier Investments (U.K.) Ltd	11,10,94,700	0	30/9/2023
0.23851 %	Dimensional Fund Advisors, L.P.	11,02,94,600	0	31/3/2024
0.20812 %	Geode Capital Management, L.L.C.	9,62,39,499	11,25,600	29/2/2024
0.20547 %	Amundi Asset Management, SAS	9,50,17,900	94,14,600	31/3/2024
0.19694 %	Hadiana (Ronny)	9,10,71,007	-34,00,000	31/12/2022
0.17622 %	Capital Research Global Investors	8,14,87,800	-34,28,100	31/3/2024
0.17335 %	Frostrow Capital LLP	8,01,61,100	0	31/12/2023
0.13574 %	Robeco Institutional Asset Management B.V.	6,27,71,400	8,99,100	31/3/2024
0.12254 %	Boston Common Asset Management, LLC	5,66,67,767	1,35,10,397	31/3/2024
0.12132 %	State Street Global Advisors (US)	5,61,02,037	-30,000	31/3/2024
0.11564 %	AEGON Investment Management B.V.	5,34,77,602	4,79,80,327	31/12/2023
0.10812 %	Aubrey Capital Management Ltd.	5,00,00,000	0	31/12/2023
0.09723 %	UBS Asset Management (UK) Ltd.	4,49,60,100	1,47,400	31/3/2024
0.08739 %	Aviva Investors Global Services Limited	4,04,11,360	33,96,835	29/2/2024
0.08718 %	Northern Trust Global Investments Limited	4,03,13,000	14,50,700	29/2/2024
0.07999 %	Caisse de Depot et Placement du Quebec	3,69,90,522	1,16,39,178	31/12/2022
0.07442 %	Credit Suisse Funds AG	3,44,13,300	-21,48,200	31/3/2024
0.06854 %	Royal London Asset Management (CIS) Limited_NLE	3,16,96,400	0	31/8/2023
0.06854 %	Royal London Asset Management Ltd.	3,16,96,400	0	31/12/2023
0.06706 %	Storebrand Kapitalforvaltning AS	3,10,10,730	0	29/2/2024
0.06648 %	BlackRock Investment Management (UK) Ltd.	3,07,44,693	0	29/2/2024
0.06363 %	Amundi Japan Ltd.	2,94,22,300	4,76,600	31/3/2024
0.06056 %	Nuveen LLC	2,80,04,606	0	31/3/2024
0.05843 %	State Street Global Advisors (UK) Ltd.	2,70,20,127	38	31/3/2024
0.05630 %	Manulife Investment Management (North America) Limited	2,60,35,225	0	29/2/2024
0.05352 %	Capital International, Inc.	2,47,50,000	0	31/12/2023
0.05317 %	DWS Investments UK Limited	2,45,89,714	11,77,312	31/3/2024
0.05190 %	HSBC Global Asset Management (UK) Limited	2,40,00,786	1,00,898	29/2/2024
0.05160 %	Charles Schwab Investment Management, Inc.	2,38,60,602	0	31/3/2024
0.05049 %	Rainier Investment Management, LLC	2,33,47,400	-30,69,900	31/1/2024
0.04863 %	Handelsbanken Kapitalförvaltning AB	2,24,88,400	11,09,600	31/3/2024
0.04668 %	Setiady (Bernadette Ruth Irawati)	2,15,88,000	0	31/12/2022
0.04451 %	McInroy & Wood Ltd.	2,05,81,100	0	31/12/2023
0.04439 %	ABN AMRO Investment Solutions (AAIS)	2,05,27,895	1	29/2/2024
0.04090 %	UBS Asset Management (Switzerland)	1,89,14,800	0	29/2/2024
0.03964 %	American Century Investment Management, Inc.	1,83,29,800	13,66,900	31/3/2024
0.03775 %	DWS Investment GmbH	1,74,54,600	10,71,500	31/3/2024
0.03445 %	Mellon Investments Corporation	1,59,29,431	-11,62,300	31/3/2024
0.03285 %	Zürcher Kantonalbank (Asset Management)	1,51,91,400	0	29/2/2024
0.03241 %	SEI Investments Management Corporation	1,49,88,159	0	31/3/2024
0.03207 %	California State Teachers Retirement System	1,48,28,890	-1,82,22,000	30/6/2023
0.03163 %	Parametric Portfolio Associates LLC	1,46,25,400	0	31/1/2024
0.03113 %	Mercer Global Investments Management Ltd	1,43,95,700	0	31/3/2024
0.02958 %	PGGM Vermogensbeheer B.V.	1,36,80,404	33,068	31/7/2023
0.02739 %	Pictet Asset Management Ltd.	1,26,63,800	0	31/12/2023
0.02722 %	Manulife Investment Management (M) Berhad	1,25,87,900	-4,70,800	30/9/2023
0.02700 %	Dimensional Fund Advisors, Ltd.	1,24,87,000	3,74,100	29/2/2024
0.02644 %	Goldman Sachs Asset Management, L.P.	1,22,26,419	-3,40,296	31/3/2024
0.02575 %	Asset Management One Co., Ltd.	1,19,09,018	-8,44,600	31/5/2023
0.02563 %	First Sentier Investors (Singapore)	1,18,51,400	0	31/12/2023
0.02466 %	GAM (Hong Kong) Ltd.	1,14,04,600	0	31/12/2023
0.02251 %	Capital International Sarl	1,04,09,100	0	29/2/2024
0.02204 %	Legal & General Investment Management Ltd.	1,01,90,900	0	31/3/2024
0.02159 %	BlackRock (Singapore) Limited	99,83,070	46,05,744	31/3/2024
0.02102 %	Research Affiliates, LLC	97,19,800	-5,82,900	31/12/2023
0.02087 %	HSBC Global Asset Management (Singapore) Limited	96,49,500	0	31/12/2023
0.02074 %	Fideuram Asset Management (Ireland) dac	95,92,500	95,32,200	29/2/2024
0.02010 %	Oaktree Capital Management, L.P.	92,93,587	0	30/6/2023
0.01962 %	Cardano Asset Management NV	90,71,369	1,073	29/2/2024
0.01886 %	Eurizon Capital S.A.	87,21,802	-26,14,000	29/2/2024
0.01872 %	Deutsche Asset Management Americas	86,55,218	-1,69,621	31/3/2024
0.01865 %	Trinetra Investment Management LLP	86,22,500	0	31/12/2023
0.01778 %	Lazard Asset Management, L.L.C.	82,23,000	82,00,600	31/12/2023
0.01734 %	Fukoku Capital Management Inc.	80,19,700	80,19,700	30/6/2023
0.01681 %	ETF Architect	77,72,250	1,64,310	31/3/2024
0.01478 %	Prusik Investment Management LLP	68,34,700	-10,07,100	31/12/2023
0.01465 %	Florida State Board of Administration	67,73,900	67,73,900	30/9/2022
0.01457 %	Nikko Asset Management Asia Limited	67,39,700	67,39,700	30/6/2023
0.01455 %	abrdn Asia Limited	67,29,300	6,05,200	30/9/2023
0.01421 %	Neuberger Berman, LLC	65,70,400	0	31/7/2023
0.01381 %	State Street Global Advisors Ireland Limited	63,86,800	-62,400	31/3/2024
0.01231 %	UOB Asset Management Ltd.	56,92,300	53,90,000	30/6/2023
0.01220 %	Alps Advisors, Inc.	56,41,000	9,01,400	31/3/2024
0.01198 %	Vanguard Investments Australia Ltd.	55,40,934	3,090	29/2/2024
0.01174 %	Nykredit Bank AS	54,27,500	25,37,500	29/2/2024
0.01162 %	i-VCAP Management Sdn. Bhd.	53,74,345	-69,988	31/1/2024
0.01073 %	Northern Trust Investments, Inc.	49,62,980	-3,50,400	31/3/2024
0.01065 %	UBS Asset Management Switzerland AG	49,24,900	0	29/2/2024
0.01028 %	Van Eck Associates Corporation	47,53,600	-2,58,300	31/3/2024
0.00989 %	Columbia Threadneedle Investments (UK)	45,72,500	-4,70,300	31/8/2023
0.00967 %	KLP Fondsforvaltning AS	44,73,900	0	29/2/2024
0.00895 %	Swedbank Robur Fonder AB	41,39,700	0	29/2/2024
0.00839 %	AMF Tjänstepension AB	38,80,100	0	29/2/2024
0.00812 %	AXA Investment Managers Asia Limited	37,54,600	0	29/2/2024
0.00809 %	Lion Global Investors Limited	37,41,564	17	31/12/2023

What values and corporate philosophy does Kalbe Farma Tbk PT represent?

Kalbe Farma Tbk PT is a leading pharmaceutical company that upholds strong values and a well-defined corporate philosophy. With a commitment to excellence and a focus on innovation, Kalbe Farma Tbk PT strives to improve the health and well-being of individuals and communities. The company believes in providing high-quality healthcare solutions that are accessible, affordable, and sustainable. Kalbe Farma Tbk PT also places great importance on ethical conduct, transparency, and accountability in its operations. Through its dedication to continuous improvement and customer satisfaction, Kalbe Farma Tbk PT has earned a reputation as a trusted and reliable provider of pharmaceutical products and services.

In which countries and regions is Kalbe Farma Tbk PT primarily present?

Kalbe Farma Tbk PT is primarily present in Indonesia.

What significant milestones has the company Kalbe Farma Tbk PT achieved?

Kalbe Farma Tbk PT has achieved several significant milestones over the years. The company has successfully established itself as a leading pharmaceutical and healthcare provider in Indonesia. It has expanded its product portfolio, offering a wide range of quality medicines, nutritional products, and health supplements. Kalbe Farma Tbk PT has also made significant advancements in research and development, introducing innovative solutions and improving healthcare access for the Indonesian population. The company's strong focus on technology and digitalization has further propelled its growth and reach. With its commitment to excellent customer service and continuous improvement, Kalbe Farma Tbk PT continues to thrive in the highly competitive pharmaceutical industry.

What is the history and background of the company Kalbe Farma Tbk PT?

Kalbe Farma Tbk PT is a leading pharmaceutical company based in Indonesia. Founded in 1966, Kalbe Farma has since grown to become one of the largest and most successful healthcare enterprises in the country. With a strong focus on research and development, the company continuously strives to provide innovative and high-quality products to meet the diverse needs of its customers. Kalbe Farma's extensive range of pharmaceuticals, nutritional products, and over-the-counter drugs cater to various therapeutic areas. Over the years, the company has garnered a strong reputation for its commitment to excellence and its contribution to improving the healthcare sector in Indonesia.

Who are the main competitors of Kalbe Farma Tbk PT in the market?

The main competitors of Kalbe Farma Tbk PT in the market include companies such as Sanbe Farma, Dexa Medica, Kimia Farma, and Tempo Scan Pacific.

In which industries is Kalbe Farma Tbk PT primarily active?

Kalbe Farma Tbk PT is primarily active in the pharmaceutical industry.

What is the business model of Kalbe Farma Tbk PT?

The business model of Kalbe Farma Tbk PT is focused on the healthcare industry. As one of the largest pharmaceutical companies in Indonesia, Kalbe Farma Tbk PT operates through various segments, including Prescription Pharmaceuticals, Consumer Health, and Distribution & Logistics. Their business model relies on research and development, manufacturing, marketing, and distribution of a wide range of pharmaceutical products, such as medicines, vitamins, supplements, and health foods. By providing quality and affordable healthcare solutions, Kalbe Farma Tbk PT aims to improve the well-being of individuals and contribute to the overall health of the community.

Kalbe Farma Tbk PT 2024 की कौन सी KGV है?

Kalbe Farma Tbk PT का केजीवी 24.82 है।

Kalbe Farma Tbk PT 2024 की केयूवी क्या है?

Kalbe Farma Tbk PT KUV 2.64 है।

Kalbe Farma Tbk PT का AlleAktien गुणवत्ता स्कोर क्या है?

Kalbe Farma Tbk PT के लिए AlleAktien गुणवत्ता स्कोर 6/10 है।

Kalbe Farma Tbk PT 2024 का वार्षिक कारोबार कितना है?

अपेक्षित Kalbe Farma Tbk PT का व्यापार वोल्यूम 30.17 जैव. IDR है।

Kalbe Farma Tbk PT 2024 का लाभ कितना है?

अपेक्षित Kalbe Farma Tbk PT लाभ 3.21 जैव. IDR है।

Kalbe Farma Tbk PT क्या करता है?

Kalbe Farma Tbk PT is the largest pharmaceutical company in Indonesia and is one of the leading Southeast Asian companies in the healthcare industry. The company was founded in 1966 and has since built a portfolio of over 1,500 products. Kalbe Farma offers a wide range of products and services in the health, nutrition, and wellness sectors. The different divisions of Kalbe Farma include pharmaceuticals, dietary supplements, healthcare products, diagnostics, and medical equipment. In the pharmaceutical division, the company produces antibiotics, antivirals, vitamins, cardiovascular medications, and hormones, among others. Kalbe Farma's dietary supplements include vitamins, minerals, and herbal products that contribute to health and well-being. The company also has a wide range of healthcare products that contain therapeutic support and health-promoting ingredients. These include cosmetic products or care items for individuals with diabetes or other specific health problems. The company's diagnostics division offers a specialized portfolio of medical laboratory equipment and services for diagnosis and research. In the medical equipment division, Kalbe Farma offers endoscopic systems for gastroenterological examinations and ventilation-related medical equipment for healthcare facilities. Kalbe Farma also operates a number of subsidiaries and joint ventures that focus on specialized services and products for specific target groups. Among other things, the company has a range of investments in the animal health and animal products sector. Kalbe Farma's business model has several success factors. The company has comprehensive expertise in the production and development of healthcare products for a wide range of applications. Due to its size, flexibility, and product diversity, Kalbe Farma is able to cover a broad range of customer needs. The company is also heavily involved in research and development to ensure that it stays at the forefront of medical innovation. Another strength of the company is its ability to constantly renew its portfolio and adapt to the changing needs of the market. This is achieved, for example, through the continuous introduction of new products, services, and technologies that offer customers high quality and effectiveness. Overall, Kalbe Farma has a strong business model with a wide range of products and services and a strong focus on scientific research and innovation. The company also has a strong presence in Southeast Asia and is therefore able to serve various needs of the rapidly growing healthcare markets in this region.

Kalbe Farma Tbk PT डिविडेंड कितना है?

Kalbe Farma Tbk PT एक वर्ष में बार वितरण करते हुए 0 IDR का डिविडेंड देता है।

Kalbe Farma Tbk PT कितनी बार लाभांश देती है?

वर्तमान में Kalbe Farma Tbk PT के लिए डिविडेंड की गणना नहीं की जा सकती है या फिर कंपनी डिविडेंड नहीं दे रही है।

Kalbe Farma Tbk PT ISIN क्या है?

Kalbe Farma Tbk PT का ISIN ID1000125107 है।

Kalbe Farma Tbk PT WKN क्या है?

Kalbe Farma Tbk PT का WKN A1J5U9 है।

Kalbe Farma Tbk PT टिकर क्या है?

Kalbe Farma Tbk PT का टिकर KLBF.JK है।

Kalbe Farma Tbk PT कितना लाभांश देती है?

पिछले 12 महीनों में Kalbe Farma Tbk PT ने 38 IDR का डिविडेंड भुगतान किया। यह लगभग 2.21 % के डिविडेंड यील्ड के बराबर है। आगामी 12 महीनों के लिए Kalbe Farma Tbk PT अनुमानतः 41.54 IDR का डिविडेंड भुगतान करेगी।

Kalbe Farma Tbk PT का डिविडेंड यील्ड कितना है?

Kalbe Farma Tbk PT का वर्तमान डिविडेंड यील्ड 2.21 % है।

Kalbe Farma Tbk PT कब लाभांश देगी?

Kalbe Farma Tbk PT तिमाही आधार पर लाभांश का भुगतान करता है। यह जुलाई, जून, जून, जून महीनों में वितरित किया जाता है।

Kalbe Farma Tbk PT का लाभांश कितना सुरक्षित है?

Kalbe Farma Tbk PT ने पिछले 4 वर्षों में हर साल डिविडेंड का भुगतान किया।

Kalbe Farma Tbk PT का लाभांश कितना है?

आने वाले 12 महीनों के लिए 41.54 IDR के डिविडेंड की उम्मीद की जा रही है। यह 2.42 % के डिविडेंड यील्ड के बराबर है।

Kalbe Farma Tbk PT किस सेक्टर में है?

Kalbe Farma Tbk PT को 'स्वास्थ्य' क्षेत्र से संबद्ध किया गया है।

Wann musste ich die Aktien von Kalbe Farma Tbk PT kaufen, um die vorherige Dividende zu erhalten?

Kalbe Farma Tbk PT का आखिरी लाभांश प्राप्त करने के लिए, जो 14/6/2024 को 0 IDR की राशि में था, आपको Ex-दिन 30/5/2024 से पहले इसे अपनी डिपो में रखना आवश्यक था।

Kalbe Farma Tbk PT ने आखिरी बार लाभांश कब भुगतान किया था?

अंतिम लाभांश का भुगतान 14/6/2024 को किया गया था।

Kalbe Farma Tbk PT का लाभांश 2023 में कितना था?

2023 में Kalbe Farma Tbk PT द्वारा 0 IDR डिविडेंड के रूप में वितरित किए गए थे।

Kalbe Farma Tbk PT डिविडेंड किस मुद्रा में वितरित करता है?

Kalbe Farma Tbk PT के दिविडेंड IDR में वितरित किए जाते हैं।

1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0.5	0.28	0.9	0.48	0.25	0.27	0.51	0.95	1.25	1.8	1.52	1.29	1.45	1.63	1.91	2.41	2.1	1.61	2.09	2.87	3.07	2.97	3.33	3.24	5.4	6.48	4.1	3.4
0.13	0.13	0.17	0.23	0.34	0.4	0.44	0.51	0.59	0.58	0.65	0.87	0.94	1.2	1.26	1.53	1.81	2.15	2.35	2.35	2.63	2.88	3.26	3.57	3.48	3.43	4.61	4.65
51.31	450.34	24.28	16.6	21.05	26.85	29.55	34.53	27.04	52.86	108.1	57.5	65.8	114.14	101.25	105.32	132.92	128.16	117.96	79.3	94.6	91.28	118.02	124.81	117.71	114.12	174.14	168.17
0.08	0.1	0.13	0.2	0.28	0.34	0.33	0.31	0.45	1.09	0.88	1.43	1.61	1.56	1.62	1.77	2.12	3.05	3.09	3	3.34	3.56	3.47	3.74	3.6	5.09	7.03	6.79
25.19	11.22	15.69	355.92	23.84	20.33	24.79	19.43	45.25	127.87	155.09	113.69	114.22	197.17	148.17	143.58	289.22	556.24	471.36	436.89	427.41	547.56	468.09	550.75	484.41	604.6	800.03	907.69
0.79	0.98	1.24	1.28	0.91	1.06	1.33	1.82	2.36	3.65	3.32	3.76	4.17	4.7	5.04	5.96	6.44	7.5	8.12	8.75	9.57	10.04	10.65	11.22	13.08	15.71	16.71	15.92
0.26	0.28	0.51	0.53	0.61	0.69	0.78	0.87	0.95	1.43	1.73	2.04	2.32	2.55	2.76	3.18	2.25	2.93	3.4	3.94	4.56	5.34	6.25	7.67	8.31	8.31	8.32	8.51
58.55	6.78	247.42	183.68	234.44	198.93	52.84	0	0	0	0	0.7	0	0	11.03	53.71	48.95	42.42	40.83	57.65	89.13	78.86	86.11	91.06	123.34	303.27	384.54	450.8
0	36.02	0	0	20.06	17.57	28	19.44	18.07	33.82	21.92	29	48.84	39.08	29.42	28.38	26.39	34.04	30.72	83.63	34.84	28.5	54.35	52.69	35.25	43.58	93.18	142.44
-0.08	-0.06	-0.08	-0.13	-0.17	-0.22	-0.28	-0.32	-0.37	-0.54	-0.67	-0.79	-0.93	-1.1	-1.12	-1.29	0.04	0.09	0.13	0.12	0.11	0.13	0.14	0.37	0.46	0.94	1.04	1.3
32.17	53.53	50.45	50.37	44.09	40.9	37.71	34.54	30.73	36.12	32.09	28.06	24.27	210.68	195.22	195.22	298.59	294.02	293.28	293.28	293.28	293.28	293.28	293.28	195.23	209.68	479.35	479.35
250.63	895.1	57.57	89.73	110.67	97.83	67.78	26.27	30	117.01	195.41	73.33	77.18	81.99	111.96	143.04	304.97	430.46	420.75	452.87	573.54	702.7	671.22	569.62	360.22	152.09	214.8	253.03
0.52	1.22	0.78	0.73	0.84	0.82	0.68	0.63	0.66	1.07	1.3	1.38	1.54	1.78	2	2.32	2.98	3.82	4.32	4.95	5.65	6.57	7.5	9.04	9.49	9.95	10.53	11.14
1.31	2.19	2.02	2.01	1.76	1.88	2.02	2.45	3.02	4.73	4.62	5.14	5.7	6.48	7.03	8.27	9.42	11.32	12.44	13.7	15.23	16.62	18.15	20.26	22.56	25.67	27.24	27.06

216	216	216	216	406.08	406.08	406.08	406.08	406.08	507.8	507.8	507.8	507.8	507.8	507.8	507.8	507.8	468.75	468.75	468.75	468.75	468.75	468.75	468.75	468.75	468.75	468.75	468.75
18.05	2.64	2.64	2.64	2.64	2.64	2.64	2.64	2.64	2.64	2.64	2.64	2.64	2.64	4.44	4.44	-32.32	-34.12	-34.12	-34.12	-34.12	-34.12	-34.12	-34.12	-34.12	-34.12	-34.12	-34.12
0.19	0.08	-0.31	-0.01	-0.23	-0.2	0.07	0.38	0.74	1.88	2.5	3.11	3.72	4.53	5.58	6.41	7.25	7.63	8.89	10.01	11.42	12.79	14.07	15.36	16.88	19.12	20.87	21.88
0	0	20.79	22.77	17.33	18.12	19.12	28.02	38.5	-26.8	-35.46	-33.24	-31.41	-40.8	-32.22	263.47	0.27	33.38	-6.8	19.37	26.3	21.44	73.66	41.37	58.18	-50.61	-22.29	5.88
0	0	0	0	-3.63	-4.81	-3.6	11.78	27.32	24.62	18.35	21.83	-4.65	0.1	-0.21	20.06	14.85	7.04	9.46	4.73	32.83	36.88	42.06	56.01	39.11	73.99	101.9	98.34
0.43	0.3	-0.07	0.23	0.19	0.22	0.49	0.83	1.22	2.39	2.99	3.61	4.19	5	6.06	7.2	7.74	8.11	9.33	10.47	11.91	13.28	14.62	15.89	17.41	19.58	21.39	22.42
0.02	0.03	0.04	0.04	0.07	0.1	0.1	0.1	0.15	0.31	0.34	0.33	0.31	0.48	0.49	0.89	0.81	1.15	1.13	1.07	1.13	1.11	1.29	1.22	1.24	1.67	2	1.69
22.67	34.6	50.86	59.14	77.66	111.82	132.74	161.33	213.11	228.82	119.48	207.4	269.37	359.98	301.96	283.14	391.36	338.91	393.59	440.67	408.98	322.03	301.1	469.46	481.95	710.94	601.33	478.54
0.03	0.13	0.02	0.08	0.06	0.07	0.09	0.12	0.14	0.2	0.16	0.17	0.27	0.39	0.33	0.32	0.49	0.57	0.61	0.59	0.63	0.62	0.6	0.72	1.09	1.06	0.98	0.77
0.1	0.33	1.06	0.04	0.08	0.09	0.05	0.03	0.03	0.02	0.03	0.04	0.15	0.34	0.02	0.14	0.2	0.58	0.25	0.27	0.15	0.17	0.07	0.15	0.22	0	0.71	0.12
0.02	1.22	0.86	0.5	0.14	0.13	0.76	0.75	0.25	0.15	0.01	0	0.26	0	0	0	0	0	0	0	0	0	0.03	0.02	0.15	0.09	0.15	0.18
0.19	1.75	2.03	0.72	0.43	0.5	1.13	1.16	0.78	0.9	0.66	0.75	1.25	1.57	1.15	1.63	1.89	2.64	2.39	2.37	2.32	2.23	2.29	2.58	3.18	3.53	4.43	3.24
611.75	84.27	9.14	941.25	994.17	997.96	208.78	231.68	684.59	839.11	339.93	267.97	0.49	1.05	0.75	0.37	0.08	0	44.22	130.93	134.42	145.6	260	647.69	788.55	532.51	311.9	321.14
0	0	0	1.79	3.5	5.11	5.9	7.6	14.95	11.98	10.77	10	7.71	8.33	7.64	9.84	10.93	11.93	11.3	6.6	0.58	0.64	0.13	0.24	2.59	19.57	32.5	35.79
0	0	0	19.99	21.36	27.8	15.78	24.3	55.25	67.42	71.11	88.95	100.72	108.27	105.71	117.83	143.69	162.58	233.73	254.72	310	348.63	305.31	334.11	320.35	314.02	368.55	337.44
0.61	0.08	0.01	0.96	1.02	1.03	0.23	0.26	0.75	0.92	0.42	0.37	0.11	0.12	0.11	0.13	0.15	0.17	0.29	0.39	0.45	0.49	0.57	0.98	1.11	0.87	0.71	0.69
0.81	1.83	2.04	1.68	1.45	1.53	1.36	1.42	1.54	1.82	1.08	1.12	1.36	1.69	1.26	1.76	2.05	2.82	2.68	2.76	2.76	2.72	2.85	3.56	4.29	4.4	5.14	3.94
1.23	2.13	1.97	1.91	1.64	1.75	1.85	2.25	2.76	4.21	4.08	4.73	5.55	6.69	7.32	8.96	9.79	10.92	12.01	13.22	14.67	16	17.48	19.45	21.7	23.98	26.53	26.36

1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3.18	3.38
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	664.21	701.37
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
104.07	41.92	616.26	188.73	-326.1	-535.84	-652.88	-817.62	-911.81	-1,342.16	-1,494.16	-1,786.43	-2,143.34	-1,896.43	-2,834.51	-3,133.6	-4,532.71	-6,508.97	-6,967.66	-7,279.64	-8,137.57	-8,676.42	-8,300.46	-8,785.21	-8,239.06	-9,227.54	-9,795.85
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	-1.03 मिलियन	-2.84 मिलियन
0	0	0	0	-133.16	-137.63	-118.84	-65.74	-86	-98.82	-65.06	0	0	0	0	0	0	0	0	0	0	0	0	0	0	66.57	53.59
0	0	0	0	-1,92,818	-1,59,633	-1,84,638	-2,03,064	-3,57,022	-5,55,522	-5,56,812	-3,89,430	-3,48,093	-3,77,014	-4,14,507	-4,19,172	-5,05,558	-6,45,596	-6,39,719	-6,88,576	-7,31,822	-7,51,411	-8,35,148	-8,18,595	-5,92,189	-9,65,742	-1.15 मिलियन
0.1	0.04	0.62	0.19	0.1	0.17	0.4	0.51	0.43	0.53	0.64	0.36	0.81	1.36	1.15	1.47	1.38	0.93	2.32	2.46	2.16	2.01	2.77	2.5	4.21	2.83	1.27
-49,798	-38,658	-12,953	-34,000	-90,511	-85,457	-1,01,823	-1,25,425	-1,15,153	-4,02,139	-3,32,068	-2,24,597	-3,05,198	-2,77,597	-4,69,775	-4,71,233	-7,89,884	-1.03 मिलियन	-7,78,750	-9,30,318	-1.1 मिलियन	-1.24 मिलियन	-1.37 मिलियन	-1.98 मिलियन	-1.12 मिलियन	-1 मिलियन	-8,70,100
-4.64	-455.09	-1.96	-343.21	253.54	-58.98	-99.35	-397.25	-277.71	-117.39	260.11	-42.27	-186.23	-645.44	-232.13	-630.95	-914.53	-882.15	-676.51	-801.46	-1,014.92	-1,113.56	-1,289.83	-1,900.54	-951.22	-1,056.02	-1,370.39
45.16	-416.43	10.99	-309.21	344.05	26.48	2.47	-271.82	-162.56	284.75	592.18	182.33	118.97	-367.84	237.64	-159.72	-124.65	147.38	102.24	128.86	83.97	121.92	83.2	82.39	166.99	-55.15	-500.29
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-42.97	227.08	1.75	-271.09	-606.54	-63.33	-91.31	23.69	-113.68	-304.32	-476.69	-74.05	89.79	-66.82	-314.74	115.35	31.15	309.29	-293.33	98.57	-84.28	72.4	41.84	415.98	235.05	-533.19	319.94
0	0	0	0	0	0	0	0	0	0	0	-218.31	-351.2	-125.07	1.91	0	0	0	0	0	0	0	0	0	-2.06	0	-1,001.91
-67.81	194.68	1.75	-271.09	-607.03	-89.38	-105.03	-9.76	-132.75	-239.98	-531.17	-473.79	-439.7	-390.74	-574.67	-406.98	-921.27	-613.32	-1,177.27	-861.5	-941.4	-976.39	-1,139.66	-706.92	-1,099.71	-745.18	-2,405.75
0	0	0	0	0.01	-0.01	-0.01	-0.02	-0.01	0.09	-0.05	-0.08	-0.08	-0.08	-0.03	0.03	-0.06	-0.03	-0.09	-0.07	0.03	-0.02	-0.01	0.1	-0.08	1.16	-0.04
-24,840	-32,400	0	0	-6,842	-14,155	-6,946	-15,384	-7,456	-28,074	-1,621	-1,00,786	-96,708	-1,17,234	-2,34,376	-5,49,528	-8,90,627	-8,90,627	-7,96,877	-8,90,627	-8,90,627	-1.03 मिलियन	-1.17 मिलियन	-1.22 मिलियन	-1.25 मिलियन	-1.37 मिलियन	-1.69 मिलियन
0.03	-0.22	0.62	-0.43	0.5	1.03	1.54	1.68	1.79	2.72	3.1	2.39	3.5	3.88	4.74	5.42	5.95	7.61	10.39	11.26	11.23	11.36	12.27	11.95	15.26	14.03	9.95
54,270	3,264	6,03,303	1,54,730	7,661	83,490	2,97,305	3,81,511	3,09,920	1,32,150	3,08,542	1,38,088	5,02,503	1.09 मिलियन	6,83,817	1 मिलियन	5,86,460	-1,02,358	1.54 मिलियन	1.53 मिलियन	1.06 मिलियन	7,72,833.8	1.4 मिलियन	5,20,042.28	3.1 मिलियन	1.83 मिलियन	4,01,788.88
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

प्रत्यक्ष निर्गम	24,392.2
खरीदी गई ऊर्जा से संबंधित अप्रत्यक्ष उत्सर्जन	97,934.6
वर्तमान श्रृंखला में परोक्ष उत्सर्जन	—
CO₂ उत्सर्जन	1,22,327
CO₂-कमी रणनीति	✅
कोयला ऊर्जा	❌
परमाणु ऊर्जा	❌
प्रयोगशाला में जानवरों पर परीक्षण	❌
पेल्ज़ और लेदर	—
कीटनाशक	—
ताड़ का तेल	—
तंबाकू	❌
जेनेटिक इंजीनियरिंग	❌
क्लाइमाकॉन्ज़ेप्ट	—
स्थायी वानिकी	—
पुनर्चक्रण नियमन	❌
पर्यावरण के अनुकूल पैकेजिंग	✅
खतरनाक पदार्थ	❌
ईंधन खपत और दक्षता	✅
जल उपयोग और दक्षता	❌

महिला कर्मचारियों का प्रतिशत	32.35
प्रबंधन में महिलाओं की हिस्सेदारी	—
एशियाई कर्मचारियों की हिस्सेदारी	—
एशियाई प्रबंधन की हिस्सेदारी	—
हिस्पैनिक/लैटिनो कर्मचारियों का प्रतिशत	—
हिस्पैनो/लैटिनो प्रबंधन हिस्सा	—
श्वेत अधिकारियों का प्रतिशत	—
काले प्रबंधन की हिस्सेदारी	—
श्वेत कर्मचारियों का अनुपात	—
श्वेत प्रबंधन में हिस्सेदारी	—
वयस्क सामग्री	❌
अल्कोहल	❌
रक्षा	—
शस्त्र	❌
जुआ	❌
सैन्य अनुबंध	❌
मानवाधिकार अवधारणा	✅
गोपनीयता नीतи	—
काम और स्वास्थ्य सुरक्षा	✅
कैथोलिक	✅

स्थिरता रिपोर्ट	✅
स्टेकहोल्डर-इंगेजमेंट	✅
नीतियाँ वापस बुलाने की	❌
प्रतिस्पर्धा कानून	❌

बाजार	Kalbe Farma Tbk PT टिकर
फ्रैंकफर्ट	LCLA.F
JKT	KLBF.JK
म्यूनिख	LCLA.MU
PNK	PTKFF

Kalbe Farma Tbk PT टिकर	Kalbe Farma Tbk PT FIGI
KLBF:IJ	BBG000BFRVS5
PTKFF:US	BBG000BRYGH6
PTKFF:UV	BBG000BRYQ02
LCLA:GR	BBG000BXWCC9
LCLA:GF	BBG000BXWCJ2
LCLA:GS	BBG000BXWDV6
LCLA:GM	BBG000BXWFD1
LCLA:GB	BBG000BXWFY8
KLBFEUR:EO	BBG00FZLJ6L4
KLBFEUR:XH	BBG00FZLJ6P0
KLBFEUR:XF	BBG00FZLJ6R8
KLBFEUR:XE	BBG00FZLJ6T6
KLBFEUR:XJ	BBG00FZLJ6V3
KLBFEUR:XL	BBG00FZLJ6W2
KLBFEUR:XG	BBG00FZLJ6X1
KLBFEUR:XO	BBG00FZLJ6Y0
KLBFEUR:XS	BBG00FZLJ732
KLBFEUR:XA	BBG00FZLJ741
KLBFEUR:E1	BBG00FZLJ750
KLBFEUR:XT	BBG00FZLJ769
KLBFEUR:XW	BBG00FZLJ778
KLBFEUR:XU	BBG00FZLJ787
KLBFEUR:XV	BBG00FZLJ796
KLBFEUR:EU	BBG00FZLJ7C2
LCLA:GZ	BBG00FZMF690
KLBFEUR:XX	BBG00JN8L298
KLBFIDR:X2	BBG00JSHLF12
KLBFIDR:XB	BBG00JSHLF21
KLBFIDR:XH	BBG00JSHLF49
KLBFIDR:XF	BBG00JSHLF67
KLBFIDR:XE	BBG00JSHLF85
KLBFIDR:XJ	BBG00JSHLF94
KLBFIDR:XL	BBG00JSHLFB1
KLBFIDR:XG	BBG00JSHLFC0
KLBFIDR:XO	BBG00JSHLFD9
KLBFIDR:XS	BBG00JSHLFJ3
KLBFIDR:XA	BBG00JSHLFK1
KLBFIDR:E1	BBG00JSHLFL0
KLBFIDR:XT	BBG00JSHLFM9
KLBFIDR:XW	BBG00JSHLFN8
KLBFIDR:XU	BBG00JSHLFP6
KLBFIDR:XV	BBG00JSHLFQ5
KLBFIDR:XM	BBG00JSHLFR4
KLBFIDR:XQ	BBG00JSHLFT2
KLBFIDR:XX	BBG00JSHLFV9
KLBFIDR:XZ	BBG00JSHLFW8
KLBFIDR:EU	BBG00JSHLFY6
LCLA:LA	BBG018H88T49
LCLA:LU	BBG018J1XWR2

अपने जीवन के सर्वश्रेष्ठ निवेश करें fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

शेयर मूल्य

शेयर मूल्य

टिकरKLBF.JK

ISINID1000125107

WKNA1J5U9

Kalbe Farma Tbk PT शेयर कीमत

कुर्स

अवलोकन

इंट्राडे सुविधा

कुल रिटर्न और सापेक्षिक मूल्य परिवर्तन

व्याख्या और निवेश

Kalbe Farma Tbk PT शेयर मूल्य इतिहास

Kalbe Farma Tbk PT शेयर बिक्री, EBIT, लाभ ID1000125107 · A1J5U9

उमसात्ज, गेविन्न & EBIT

उमसात्ज, EBIT और आय की समझ

सालाना विश्लेषण और तुलनाएँ

निवेश के लिए उम्मीदें उपयोग करें

निवेश संविधान

Kalbe Farma Tbk PT बिक्री, लाभ और ईबीआईटी इतिहास

Kalbe Farma Tbk PT शेयर मापदंड

गुआव

आय और विकास

सकल मार्जिन

EBIT और EBIT-मार्जिन

आय और विकास

शेयर बकाया

वार्षिक तुलना की व्याख्या

अपेक्षाएँ और अनुमान

बिलान्ज

बिलान्ज की समझ

संपत्तियाँ

दायित्व

मालिकाना हक

वर्ष-दर-वर्ष विश्लेषण

डेटा की व्याख्या

Kalbe Farma Tbk PT शेयर मार्जिन ID1000125107 · A1J5U9

मार्जिन

ब्रूटोमार्जिन की समझ

EBIT मार्जिन विश्लेषण

उम्सात्झ्मार्जिन अंतर्दृष्टि

अपेक्षाओं की व्याख्या

तुलनात्मक विश्लेषण

Kalbe Farma Tbk PT मार्जिन इतिहास

Kalbe Farma Tbk PT शेयर बिक्री, EBIT, प्रति शेयर लाभ ID1000125107 · A1J5U9

उमसत्ज़, EBIT और प्रति शेयर लाभ

प्रति शेयर उमसत्ज़

प्रति शेयर EBIT

प्रति शेयर आय

अनुमानित मान

Kalbe Farma Tbk PT बिक्री, लाभ और EBIT प्रति शेयर इतिहास

Kalbe Farma Tbk PT शेयर और शेयर विश्लेषण

Kalbe Farma Tbk PT Fair Value के अनुसार मूल्यांकन

Fair Value

Fair Value की समझ

आय-आधारित Fair Value

राजस्व-आधारित Fair Value

लाभांश-आधारित Fair Value

अपेक्षाएँ और अनुमान

तुलनात्मक विश्लेषण

Kalbe Farma Tbk PT का मूल्यांकन ऐतिहासिक P/E अनुपात, EBIT और P/S अनुपात के अनुसार

Kalbe Farma Tbk PT संख्या शेयर ID1000125107 · A1J5U9

उमसत्ज़, EBIT और प्रति शेयर लाभ

प्रति शेयर उमसत्ज़

प्रति शेयर EBIT

प्रति शेयर आय

अनुमानित मान

Kalbe Farma Tbk PT एक्टियन्स्प्लिट्स

Kalbe Farma Tbk PT शेयर लाभांश ID1000125107 · A1J5U9

डिविडेंड

डिविडेंड संबंधी समीक्षा

व्याख्या और प्रयोग

निवेश रणनीति

Kalbe Farma Tbk PT डिविडेंड इतिहास

Kalbe Farma Tbk PT शेयर वितरण अनुपात ID1000125107 · A1J5U9

वितरण अनुपात

वार्षिक वितरण अनुपात क्या है?

डेटा की व्याख्या कैसे करें

निवेश के लिए डेटा का उपयोग

Kalbe Farma Tbk PT वितरण अनुपात इतिहास

अपने जीवन के सर्वश्रेष्ठ निवेश करें
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

टिकर
KLBF.JK

ISIN
ID1000125107

WKN
A1J5U9